897086-96-3 Usage
General Description
HDH-PHARMA 23781 is a chemical compound designated as an antagonist for the growth hormone secretagogue receptor GHS-R1a. It is a novel synthetic analog that has shown potential for therapeutic use in treating conditions related to abnormal growth hormone secretion, such as acromegaly and pituitary adenomas. Studies have indicated that HDH-PHARMA 23781 effectively inhibits the stimulation of growth hormone release induced by ghrelin, a natural ligand for GHS-R1a, making it a promising candidate for further development as a pharmaceutical agent for addressing disorders associated with dysregulated growth hormone signaling.
Check Digit Verification of cas no
The CAS Registry Mumber 897086-96-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,7,0,8 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 897086-96:
(8*8)+(7*9)+(6*7)+(5*0)+(4*8)+(3*6)+(2*9)+(1*6)=243
243 % 10 = 3
So 897086-96-3 is a valid CAS Registry Number.
897086-96-3Relevant articles and documents
UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF
-
Paragraph 0156, (2016/02/18)
Disclosed are compounds that may be used to inhibit the action of fatty acid amide hydrolase (FAAH), monoacylglycerol lipase (MAGL) or dual FAAH/MAGL.
